Skip to main content
Clinical Trials/DRKS00003299
DRKS00003299
Recruiting
Not Applicable

Brain Magnetic Resonance Imaging at 3.0 Tesla in neurodegenerative parkinsonism – a pilot study

Medizinische Universität Innsbruck,Department für Neurologie0 sites120 target enrollmentOctober 14, 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
G20
Sponsor
Medizinische Universität Innsbruck,Department für Neurologie
Enrollment
120
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 14, 2011
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Medizinische Universität Innsbruck,Department für Neurologie

Eligibility Criteria

Inclusion Criteria

  • 1\. clinical diagnosis of PD, MSA or PSP obtained by a neurologist according to published clinical diagnostic criteria;
  • 2\. the patient has the ability to communicate well with the investigator and comply with the requirements of the study;
  • 3\. written informed consent is obtained;
  • healthy controls:
  • 1\. the subject has the ability to communicate well with the investigator and comply with the requirements of the study;
  • 2\. written informed consent is obtained;

Exclusion Criteria

  • 1\. History of other neurological or psychiatric disorders or conditions;
  • 2\. the subject has a history of alcohol, narcotic, or any other drug abuse as defined by the Diagnostic and Statistical Manual of the American Psychiatric Association, 4th Edition (DSM\-IV);
  • 3\. the subject is pregnant;
  • 4\. the subject is unsuitable for an MRI study (e.g. Pacemakers);
  • healthy controls:
  • 1\. History of neurological or psychiatric disorders or conditions;
  • 2\. the subject has a history of alcohol, narcotic, or any other drug abuse as defined by the Diagnostic and Statistical Manual of the American Psychiatric Association, 4th Edition (DSM\-IV);
  • 3\. the subject is pregnant;
  • 4\. the subject is unsuitable for an MRI study

Outcomes

Primary Outcomes

Not specified

Similar Trials